Article Information
History
- December 15, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Chandima Jeewandara1,
- Inoka Sepali Aberathna1,
- Saubhagya Danasekara1,
- Laksiri Gomes1,
- Suranga Fernando2,
- Dinuka Guruge3,
- Thushali Ranasinghe1,
- Banuri Gunasekera1,
- Achala Kamaladasa1,
- Heshan Kuruppu1,
- Gayasha Somathilake1,
- Jeewantha Jayamali1,
- Deshni Jayathilaka1,
- Helanka Dinesh Kumara Wijayatilake2,
- Pradeep Darshana Pushpakumara1,
- Michael Harvie1,
- Thashmi Nimasha1,
- Shiromi Devika Grace de Silva3,
- Ruwan Wijayamuni2,
- Lisa Schimanski4,5,
- Pramila Rijal4,5,
- Jack Tan4,5,
- Alain Townsend4,5,
- Graham S. Ogg4,5 and
- Gathsaurie Neelika Malavige1,5,*
- 1Allergy Immunology and Cell Biology Unit, Department of Immunology and Molecular Medicine, University of Sri Jayewardenepura, Nugegoda, Sri Lanka
- 2Ministry of Health, Sri Lanka
- 3Colombo Municipal Council, Colombo, Sri Lanka
- 4MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom
- 5Centre for Translational Immunology, Chinese Academy of Medical Sciences Oxford Institute, University of Oxford, Oxford, United Kingdom
- ↵*Correspondence should be addressed to: Prof. Neelika Malavige DPhil (Oxon), FRCP (Lond), FRCPath (UK), Allergy Immunology and Cell Biology Unit, Department of Immunology and Molecular Medicine, Faculty of Medical Sciences, University of Sri Jayawardanapura, Sri Lanka.Tel +94 (0) 772443193; Email: gathsaurie.malavige{at}ndm.ox.ac.uk